Regulatory cells and cell signatures in clinical transplantation tolerance

Current Opinion in Immunology

Volumn 23, Issue 5, 2011, Pages 655-659

  Newell, Kenneth A ^a   Phippard, Deborah ^b   Turka, Laurence A ^b,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Immune Tolerance Network   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LINEAGE; CYTOKINE PRODUCTION; EXPERIMENTAL ANIMAL; FOXP3 GENE; GENE; GRAFT REJECTION; HUMAN; NATURAL KILLER CELL; NONHUMAN; ORGAN TRANSPLANTATION; REGULATORY T LYMPHOCYTE; REVIEW; TRANSPLANTATION TOLERANCE;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS, CD; B-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINEAGE; CELL PROLIFERATION; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; HUMANS; MICE; ORGAN SPECIFICITY; ORGAN TRANSPLANTATION; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION TOLERANCE;

EID: 80053608534     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2011.07.008     Document Type: Review

References (51)

1. Lamb K.E., Lodhi S., Meier-Kriesche H.U. Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant 2011, 11:450-462.
2. Lodhi S.A., Lamb K.E., Meier-Kriesche H.U. Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success. Am J Transplant 2011, 11:1226-1235.
3. Kingsley C.I., Nadig S.N., Wood K.J. Transplantation tolerance: lessons from experimental rodent models. Transpl Int 2007, 20:828-841.
4. Sykes M. Immune tolerance: mechanisms and application in clinical transplantation. J Intern Med 2007, 262:288-310.
5. Hall B.M., Pearce N.W., Gurley K.E., Dorsch S.E. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action. J Exp Med 1990, 171:141-157.
6. Li X.C., Turka L.A. An update on regulatory T cells in transplant tolerance and rejection. Nat Rev Nephrol 2010, 6:577-583.
7. Wieckiewicz J., Goto R., Wood K.J. T regulatory cells and the control of alloimmunity: from characterisation to clinical application. Curr Opin Immunol 2010, 22:662-668.
8. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003, 4:330-336.
9. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
10. Khattri R., Cox T., Yasayko S.A., Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003, 4:337-342.
11. Lal G., Bromberg J.S. Epigenetic mechanisms of regulation of Foxp3 expression. Blood 2009, 114:3727-3735.
12. Groux H., O'Garra A., Bigler M., Rouleau M., Antonenko S., de Vries J.E., Roncarolo M.G. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997, 389:737-742.
13. Faria A.M., Weiner H.L. Oral tolerance. Immunol Rev 2005, 206:232-259.
14. Collison L.W., Workman C.J., Kuo T.T., Boyd K., Wang Y., Vignali K.M., Cross R., Sehy D., Blumberg R.S., Vignali D.A. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007, 450:566-569.
15. Vlad G., Cortesini R., Suciu-Foca N. CD8+ T suppressor cells and the ILT3 master switch. Hum Immunol 2008, 69:681-686.
16. Zhang Z.X., Yang L., Young K.J., DuTemple B., Zhang L. Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat Med 2000, 6:782-789.
17. Seino K.I., Fukao K., Muramoto K., Yanagisawa K., Takada Y., Kakuta S., Iwakura Y., Van Kaer L., Takeda K., Nakayama T., et al. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc Natl Acad Sci USA 2001, 98:2577-2581.
18. Hayday A., Tigelaar R. Immunoregulation in the tissues by gammadelta T cells. Nat Rev Immunol 2003, 3:233-242.
19. Martinez-Llordella M., Puig-Pey I., Orlando G., Ramoni M., Tisone G., Rimola A., Lerut J., Latinne D., Margarit C., Bilbao I., et al. Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant 2007, 7:309-319.
20. Zarkhin V., Chalasani G., Sarwal M.M. The yin and yang of B cells in graft rejection and tolerance. Transplant Rev (Orlando) 2010, 24:67-78.
21. Safinia N., Sagoo P., Lechler R., Lombardi G. Adoptive regulatory T cell therapy: challenges in clinical transplantation. Curr Opin Organ Transplant 2010, 15:427-434.
22. Allan S.E., Crome S.Q., Crellin N.K., Passerini L., Steiner T.S., Bacchetta R., Roncarolo M.G., Levings M.K. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 2007, 19:345-354.
23. Liu W., Putnam A.L., Xu-Yu Z., Szot G.L., Lee M.R., Zhu S., Gottlieb P.A., Kapranov P., Gingeras T.R., Fazekas de St Groth B., et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006, 203:1701-1711.
24. Seddiki N., Santner-Nanan B., Martinson J., Zaunders J., Sasson S., Landay A., Solomon M., Selby W., Alexander S.I., Nanan R., et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006, 203:1693-1700.
25. Li Y., Li X.C., Zheng X.X., Wells A.D., Turka L.A., Strom T.B. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med 1999, 5:1298-1302.
26. Battaglia M., Stabilini A., Roncarolo M.G. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 2005, 105:4743-4748.
27. Coenen J.J., Koenen H.J., van Rijssen E., Hilbrands L.B., Joosten I. Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells. Blood 2006, 107:1018-1023.
28. De Serres S.A., Yeung M.Y., Mfarrej B.G., Najafian N. Effect of biologic agents on regulatory T cells. Transplant Rev (Orlando) 2011, 25:110-116.
29. Bestard O., Cassis L., Cruzado J.M., Torras J., Franquesa M., Gil-Vernet S., Lucia M., Grinyo J.M. Costimulatory blockade with mTor inhibition abrogates effector T-cell responses allowing regulatory T-cell survival in renal transplantation. Transpl Int 2011, 24:451-460.
30. Li B., Hartono C., Ding R., Sharma V.K., Ramaswamy R., Qian B., Serur D., Mouradian J., Schwartz J.E., Suthanthiran M. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 2001, 344:947-954.
31. Muthukumar T., Dadhania D., Ding R., Snopkowski C., Naqvi R., Lee J.B., Hartono C., Li B., Sharma V.K., Seshan S.V., et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005, 353:2342-2351.
32. Neujahr D.C., Cardona A.C., Ulukpo O., Rigby M., Pelaez A., Ramirez A., Gal A.A., Force S.D., Lawrence E.C., Kirk A.D., Larsen C.P. Dynamics of human regulatory T cells in lung lavages of lung transplant recipients. Transplantation 2009, 88:521-527.
33. Baan C.C., Dijke I.E., Weimar W. Regulatory T cells in alloreactivity after clinical heart transplantation. Curr Opin Organ Transplant 2009, 14:577-582.
34. Louis S., Braudeau C., Giral M., Dupont A., Moizant F., Robillard N., Moreau A., Soulillou J.P., Brouard S. Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation 2006, 81:398-407.
35. Iwase H., Kobayashi T., Kodera Y., Miwa Y., Kuzuya T., Iwasaki K., Haneda M., Katayama A., Takeda A., Morozumi K., et al. Clinical significance of regulatory T-cell-related gene expression in peripheral blood after renal transplantation. Transplantation 2011, 91:191-198.
36. Bhorade S.M., Chen H., Molinero L., Liao C., Garrity E.R., Vigneswaran W.T., Shilling R., Sperling A., Chong A., Alegre M.L. Decreased percentage of CD4+FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome. Transplantation 2010, 90:540-546.
37. Li Y., Koshiba T., Yoshizawa A., Yonekawa Y., Masuda K., Ito A., Ueda M., Mori T., Kawamoto H., Tanaka Y., et al. Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am J Transplant 2004, 4:2118-2125.
38. Li Y., Zhao X., Cheng D., Haga H., Tsuruyama T., Wood K., Sakaguchi S., Tanaka K., Uemoto S., Koshiba T. The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients. Transplantation 2008, 86:1837-1843.
39. Nafady-Hego H., Li Y., Ohe H., Zhao X., Satoda N., Sakaguchi S., Wood K., Uemoto S., Koshiba T. The generation of donor-specific CD4+CD25++CD45RA+ naive regulatory T cells in operationally tolerant patients after pediatric living-donor liver transplantation. Transplantation 2010, 90:1547-1555.
40. Martinez-Llordella M., Lozano J.J., Puig-Pey I., Orlando G., Tisone G., Lerut J., Benitez C., Pons J.A., Parrilla P., Ramirez P., et al. Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest 2008, 118:2845-2857.
41. Puig-Pey I., Bohne F., Benitez C., Lopez M., Martinez-Llordella M., Oppenheimer F., Lozano J.J., Gonzalez-Abraldes J., Tisone G., Rimola A., Sanchez-Fueyo A. Characterization of gammadelta T cell subsets in organ transplantation. Transpl Int 2010, 23:1045-1055.
42. Andreola G., Chittenden M., Shaffer J., Cosimi A.B., Kawai T., Cotter P., Locascio S.A., Morokata T., Dey B.R., Tolkoff-Rubin N.T., et al. Mechanisms of donor-specific tolerance in recipients of haploidentical combined bone marrow/kidney transplantation. Am J Transplant 2011, 11:1236-1247.
43. Van Buskirk A.M., Burlingham W.J., Jankowska-Gan E., Chin T., Kusaka S., Geissler F., Pelletier R.P., Orosz C.G. Human allograft acceptance is associated with immune regulation. J Clin Invest 2000, 106:145-155.
44. Brouard S., Mansfield E., Braud C., Li L., Giral M., Hsieh S.C., Baeten D., Zhang M., Ashton-Chess J., Braudeau C., et al. Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci USA 2007, 104:15448-15453.
45. Newell K.A., Asare A., Kirk A.D., Gisler T.D., Bourcier K., Suthanthiran M., Burlingham W.J., Marks W.H., Sanz I., Lechler R.I., et al. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 2010, 120:1836-1847.
46. Sagoo P., Perucha E., Sawitzki B., Tomiuk S., Stephens D.A., Miqueu P., Chapman S., Craciun L., Sergeant R., Brouard S., et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest 2010, 120:1848-1861.
47. Pallier A., Hillion S., Danger R., Giral M., Racape M., Degauque N., Dugast E., Ashton-Chess J., Pettre S., Lozano J.J., et al. Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype. Kidney Int 2010, 78:503-513.
48. Mauri C., Blair P.A. Regulatory B cells in autoimmunity: developments and controversies. Nat Rev Rheumatol 2010, 6:636-643.
49. Le Texier L., Thebault P., Lavault A., Usal C., Merieau E., Quillard T., Charreau B., Soulillou J.P., Cuturi M.C., Brouard S., Chiffoleau E. Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile. Am J Transplant 2011, 11:429-438.
50. Lal G., Nakayama Y., Burrell B.E., Ding Y., Bromberg J.S. Non-humoral function of B cells is required for tolerance. Am J Transplant 2011, 11:105.
51. Chen J., Xu J., Wang Q., Sciammas R., Chong A.S. A non-redundant role for IL-10 produced by B cells in the maintenance of murine heart allograft tolerance. Am J Transplant 2011, 11:517.